Introduction
posttraumatic stress disorder, PTSD, depressive symptoms
Although there exists well-established evidence-based treatments for posttraumatic stress disorder (PTSD) (Kline, Cooper, Rytwinksi, & Feeny, As evidence for the immediate benefits of massed treatment builds, including virtually via telehealth (Held et al., 2021, Alongside understanding whether treatment gains are maintained, a question exists on the impact of massed first-line treatments on comorbid mental health issues, a common occurrence in PTSD in military personnel and veterans. Although the primary aim of prolonged exposure is to address trauma-related memories, some studies have reported the amelioration of depressive symptoms (Aderka, Foa, Applebaum, Shafran, & Gilboa-Schechtman, The aim of this paper was to extend the previously published 12-week outcomes (Dell et al., 